Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, January 1999, p. 73-76, Vol. 43, No. 1
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Efficacy of New 5-Nitroimidazoles against
Metronidazole-Susceptible and -Resistant Giardia,
Trichomonas, and Entamoeba spp.
Jacqueline A.
Upcroft,1,*
Raymond W.
Campbell,1
Kamel
Benakli,2
Peter
Upcroft,1 and
Patrice
Vanelle2
The Queensland Institute of Medical Research,
Brisbane, Queensland 4029, Australia,1 and
Laboratoire de Chimie Organique, Université de la
Méditerranée, Faculté de Pharmacie, 13385 Marseille
Cedex 05, France2
Received 17 February 1998/Returned for modification 19 June
1998/Accepted 12 October 1998
The efficacies of 12 5-nitroimidazole compounds and 1 previously
described lactam-substituted nitroimidazole with antiparasitic activity, synthesized via SRN1 and subsequent reactions,
were assayed against the protozoan parasites Giardia
duodenalis, Trichomonas vaginalis, and
Entamoeba histolytica. Two metronidazole-sensitive lines and two metronidazole-resistant lines of Giardia and
one line each of metronidazole-sensitive and -resistant
Trichomonas were tested. All except one of the compounds
were as effective or more effective than metronidazole against
Giardia and Trichomonas, but none was as
effective overall as the previously described 2-lactam-substituted
5-nitroimidazole. None of the compounds was markedly more effective
than metronidazole against Entamoeba. Significant
cross-resistance between most of the drugs tested and metronidazole was
evident among metronidazole-resistant lines of Giardia and
Trichomonas. However, some drugs were lethal to metronidazole-resistant Giardia and had minimum lethal
concentrations similar to that of metronidazole for drug-susceptible
parasites. This study emphasizes the potential in developing new
nitroimidazole drugs which are more effective than metronidazole and
which may prove to be useful clinical alternatives to metronidazole.
*
Corresponding author. Mailing address: The Queensland
Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane, Queensland 4029, Australia. Phone: 61 7 3362 0369. Fax: 61 7 3362 0105. E-mail: jacquiU{at}qimr.edu.au.
Antimicrobial Agents and Chemotherapy, January 1999, p. 73-76, Vol. 43, No. 1
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sterk, M., Muller, J., Hemphill, A., Muller, N.
(2007). Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin. Microbiology
153: 4150-4158
[Abstract]
[Full Text]
-
Muller, J., Wastling, J., Sanderson, S., Muller, N., Hemphill, A.
(2007). A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides. Antimicrob. Agents Chemother.
51: 1979-1986
[Abstract]
[Full Text]
-
Ali, V., Nozaki, T.
(2007). Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by "Amitochondriate" Protozoan Parasites. Clin. Microbiol. Rev.
20: 164-187
[Abstract]
[Full Text]
-
Shimizu, T., Tomioka, H.
(2006). Activity of Picolinic Acid in Combination with the Antiprotozoal Drug Quinacrine against Mycobacterium avium Complex.. Antimicrob. Agents Chemother.
50: 3186-3188
[Abstract]
[Full Text]
-
Muller, J., Ruhle, G., Muller, N., Rossignol, J.-F., Hemphill, A.
(2006). In Vitro Effects of Thiazolides on Giardia lamblia WB Clone C6 Cultured Axenically and in Coculture with Caco2 Cells. Antimicrob. Agents Chemother.
50: 162-170
[Abstract]
[Full Text]
-
Upcroft, J. A., Dunn, L. A., Wright, J. M., Benakli, K., Upcroft, P., Vanelle, P.
(2006). 5-Nitroimidazole Drugs Effective against Metronidazole-Resistant Trichomonas vaginalis and Giardia duodenalis. Antimicrob. Agents Chemother.
50: 344-347
[Abstract]
[Full Text]
-
Adagu, I. S., Nolder, D., Warhurst, D. C., Rossignol, J.-F.
(2002). In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J Antimicrob Chemother
49: 103-111
[Abstract]
[Full Text]
-
Upcroft, J. A., Upcroft, P.
(2001). Drug Susceptibility Testing of Anaerobic Protozoa. Antimicrob. Agents Chemother.
45: 1810-1814
[Abstract]
[Full Text]
-
Gardner, T. B., Hill, D. R.
(2001). Treatment of Giardiasis. Clin. Microbiol. Rev.
14: 114-128
[Abstract]
[Full Text]
-
Upcroft, P., Upcroft, J. A.
(2001). Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa. Clin. Microbiol. Rev.
14: 150-164
[Abstract]
[Full Text]
-
Lemee, V., Zaharia, I., Nevez, G., Rabodonirina, M., Brasseur, P., Ballet, J. J., Favennec, L.
(2000). Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. J Antimicrob Chemother
46: 819-821
[Abstract]
[Full Text]